Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danshu Capsule vs Ursodeoxycholic Acid in Preventing Choledocholithiasis Recurrence
NCT04484870Phase 4Completed
- Sponsor
- Hangzhou First People's Hospital
- Start
- Mar 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Danshu in choledocholithiasis, sponsored by Hangzhou First People's Hospital. Started Mar 2017; status: completed.
02
Drugs
Danshu
03
Conditions
choledocholithiasis
Beyond the preview
Go deeper on NCT04484870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04484870.